Preparing Europe for future health threats and crises ─ the European Medicines Agency; ensuring safe and effective medicines and medical devices

References

1. European Commission (EC). European Health Union. Brussels: EC. [Accessed: 19 Oct 2022]. Available from: https://ec.europa.eu/info/strategy/priorities-2019-2024/promoting-our-european-way-life/european-health-union_en
2. Regulation (EU) 2022/123 of the European Parliament and of the Council of 25 January 2022 on a reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices (Text with EEA relevance). Luxembourg: Official Journal of the European Union. 31 Jan 2022. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32022R0123
3. European Medicines Agency (EMA). Regulation on EMA’s extended mandate becomes applicable. Amsterdam: EMA; 1 Mar 2022. Available from: https://www.ema.europa.eu/en/news/regulation-emas-extended-mandate-becomes-applicable
4. European Medicines Agency (EMA). Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG). Amsterdam: EMA; 11 May 2022. Available from: https://www.ema.europa.eu/en/about-us/what-we-do/crisis-preparedness-management/executive-steering-group-shortages-safety-medicinal-products
5. European Medicines Agency (EMA). List of critical medicines for COVID-19 public health emergency (PHE) under Regulation (EU) 2022/123. Available from: https://www.ema.europa.eu/en/documents/other/list-critical-medicines-covid-19-public-health-emergency-phe-under-regulation-eu-2022/123_en.pdf
6. European Medicines Agency (EMA). List of critical medicines for Monkeypox public health emergency (PHE) under Regulation (EU) 2022/123. Available from: https://www.ema.europa.eu/en/documents/other/list-critical-medicines-monkeypox-public-health-emergency-phe-under-regulation-eu-2022/123_en.pdf
7. European Medicines Agency (EMA)Medicines Shortages Single Point of Contact (SPOC) Working Party. Available from: https://www.ema.europa.eu/en/committees/working-parties-other-groups/medicines-shortages-single-point-contact-spoc-working-party
8. Ferreira J. Monitoring and mitigating shortages of medicines and devices. Presentation. Amsterdam: European Medicines Agency. [Accessed: 19 Oct 2022]. Available from: https://www.ema.europa.eu/en/documents/presentation/presentation-session-1-monitoring-mitigating-shortages-medicines-devices-j-ferreira-ema_en.pdf
9. European Medicines Agency (EMA). Medical Devices. Amsterdam: EMA. [Accessed: 19 Oct 2022]. Available from: https://www.ema.europa.eu/en/human-regulatory/overview/medical-devices
10. Dias SDR. Coordinating expert panels on high-risk medical devices and in vitro diagnostics. Amsterdam: European Medicines Agency (EMA). [Accessed: 19 Oct 2022]. Available from: https://www.ema.europa.eu/en/documents/presentation/presentation-session-3-coordinating-expert-panels-high-risk-medical-devices-vitro-diagnostics-s-da_en.pdf
11. European Commission. EUDAMED - European Database on Medical Devices. Brussels: European Commission. [Accessed: 19 Oct 2022]. Available from: https://ec.europa.eu/tools/eudamed/#/screen/home
12. European Medicines Agency (EMA). Emergency Task Force (ETF); Available from: https://www.ema.europa.eu/en/committees/working-parties-other-groups/emergency-task-force-etf
13. European Medicines Agency (EMA). Data Analysis and Real World Interrogation Network (DARWIN EU). Amsterdam: EMA. [Accessed: 19 Oct 2022]. Available from: https://www.ema.europa.eu/en/about-us/how-we-work/big-data/data-analysis-real-world-interrogation-network-darwin-eu
14. Peseckyte G. EU institutions showed ‘considerable resilience’ during pandemic, audit finds. Brussels: Euractiv; 1 Sep 2022. Available from: https://www.euractiv.com/section/health-consumers/news/eu-institutions-showed-considerable-resilience-during-pandemic-audit-finds/
15. European Medicines Agency (EMA). EMA and ECDC join forces for enhanced post-marketing monitoring of COVID-19 vaccines in Europe. Amsterdam: EMA; 26 Apr 2021. Available from: https://www.ema.europa.eu/en/news/ema-ecdc-join-forces-enhanced-post-marketing-monitoring-covid-19-vaccines-europe
16. Wathion N, Frias Z. How is EMA preparing for an extended mandate. Presentation at the PCWP/HCPWP Joint meeting. Amsterdam: EMA; 1 Jun 2021. Available from: https://www.ema.europa.eu/en/documents/presentation/presentation-how-ema-preparing-extended-mandate-nwathion-zfrias-ema_en.pdf
17. European Commission. Questions and Answers: European Health Emergency preparedness and Response Authority – HERA. Brussels: European Commission 16 Sep 2021. Available from: https://ec.europa.eu/commission/presscorner/detail/en/qanda_21_4733
18. European Commission. Horizon: The EU Research and Innovation Magazine. Q&A: Future pandemics are inevitable, but we can reduce the risk. Brussels: European Commission; 16 Dec 2021. Available from: https://ec.europa.eu/research-and-innovation/en/horizon-magazine/qa-future-pandemics-are-inevitable-we-can-reduce-risk